LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 65 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2020. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $22,000 | -26.7% | 7,000 | 0.0% | 0.00% | – |
Q1 2022 | $30,000 | -9.1% | 7,000 | 0.0% | 0.00% | – |
Q4 2021 | $33,000 | +17.9% | 7,000 | 0.0% | 0.00% | – |
Q3 2021 | $28,000 | -6.7% | 7,000 | 0.0% | 0.00% | – |
Q2 2021 | $30,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
Q1 2021 | $30,000 | +11.1% | 7,000 | 0.0% | 0.00% | – |
Q4 2020 | $27,000 | -3.6% | 7,000 | 0.0% | 0.00% | – |
Q3 2020 | $28,000 | -6.7% | 7,000 | 0.0% | 0.00% | – |
Q2 2020 | $30,000 | +3.4% | 7,000 | 0.0% | 0.00% | – |
Q1 2020 | $29,000 | +3.6% | 7,000 | 0.0% | 0.00% | – |
Q4 2019 | $28,000 | -20.0% | 7,000 | +74.2% | 0.00% | – |
Q3 2019 | $35,000 | -5.4% | 4,019 | 0.0% | 0.00% | – |
Q2 2019 | $37,000 | -57.0% | 4,019 | +40.5% | 0.00% | – |
Q1 2017 | $86,000 | – | 2,860 | +9125.8% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 31 | -3.1% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 32 | +3.2% | 0.00% | – |
Q4 2015 | $1,000 | – | 31 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 3,440,419 | $110,713,000 | 17.54% |
Consonance Capital Management LP | 2,079,311 | $66,912,000 | 6.04% |
RTW INVESTMENTS, LP | 1,063,170 | $34,213,000 | 5.71% |
Broadfin Capital, LLC | 1,029,866 | $33,141,000 | 5.42% |
Perceptive Advisors | 3,388,611 | $109,046,000 | 3.62% |
SECTORAL ASSET MANAGEMENT INC | 854,301 | $27,491,000 | 3.44% |
Boxer Capital, LLC | 267,500 | $8,608,000 | 1.57% |
Ghost Tree Capital, LLC | 200,000 | $6,436,000 | 1.51% |
EMORY UNIVERSITY | 51,632 | $1,662,000 | 1.43% |
Stanley-Laman Group, Ltd. | 168,653 | $5,427,000 | 1.17% |